Quantitative risk-benefit analysis of natalizumab

OBJECTIVE: To model the long-term risks and benefits of natalizumab in individuals with relapsing multiple sclerosis (MS). METHODS: We created a Markov model to evaluate treatment effects on reducing relapses and slowing disease progression using published natural history data and clinical trial res...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Thompson, J P., Noyes, K, Dorsey, E R., Schwid, S R., Holloway, R G.
Format: Artigo
Sprog:Inglês
Udgivet: American Academy of Neurology 2008
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676947/
https://ncbi.nlm.nih.gov/pubmed/18663181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/01.wnl.0000319648.65173.7a
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker